Arbutus Biopharma Corp Operating Lease Liability
Arbutus Biopharma Corp (ABUS) had Operating Lease Liability of $746.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-23
- 2025-12-31: Operating Lease, Liability $746.00K.
- 2024-12-31: Operating Lease, Liability $1.29M.
- 2023-12-31: Operating Lease, Liability $1.77M.
- 2022-12-31: Operating Lease, Liability $2.19M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $746.00K 10-K · filed 2026-03-23 |
| 2024-12-31 | $1.29M 10-K · filed 2025-03-27 |
| 2023-12-31 | $1.77M 10-K · filed 2024-03-05 |
| 2022-12-31 | $2.19M 10-K · filed 2023-03-02 |
| 2021-12-31 | $2.61M 10-K · filed 2022-03-03 |
| 2020-12-31 | $2.98M 10-K · filed 2021-03-04 |
| 2019-12-31 | $3.36M 10-K · filed 2020-03-05 |
| 2019-09-30 | $3.47M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.64M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $3.87M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |